nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—SRD5A1—obesity	0.3	0.473	CbGaD
Levonorgestrel—SHBG—obesity	0.102	0.16	CbGaD
Levonorgestrel—AR—obesity	0.0892	0.141	CbGaD
Levonorgestrel—CYP19A1—obesity	0.0746	0.118	CbGaD
Levonorgestrel—ESR1—obesity	0.0687	0.108	CbGaD
Levonorgestrel—CYP3A4—Sibutramine—obesity	0.0241	0.27	CbGbCtD
Levonorgestrel—CYP3A4—Benzphetamine—obesity	0.0182	0.204	CbGbCtD
Levonorgestrel—CYP3A4—Bupropion—obesity	0.0155	0.174	CbGbCtD
Levonorgestrel—CYP3A4—Orlistat—obesity	0.0126	0.142	CbGbCtD
Levonorgestrel—CYP3A4—Cimetidine—obesity	0.0114	0.127	CbGbCtD
Levonorgestrel—CYP3A4—Topiramate—obesity	0.00745	0.0835	CbGbCtD
Levonorgestrel—PGR—ovarian follicle—obesity	0.00711	0.153	CbGeAlD
Levonorgestrel—CYP19A1—ovarian follicle—obesity	0.0064	0.138	CbGeAlD
Levonorgestrel—ESR1—ovarian follicle—obesity	0.00556	0.12	CbGeAlD
Levonorgestrel—SRD5A1—adrenal gland—obesity	0.00173	0.0374	CbGeAlD
Levonorgestrel—SHBG—hindbrain—obesity	0.00171	0.0368	CbGeAlD
Levonorgestrel—PGR—hindbrain—obesity	0.00154	0.0331	CbGeAlD
Levonorgestrel—SRD5A1—endocrine gland—obesity	0.0015	0.0324	CbGeAlD
Levonorgestrel—SRD5A1—liver—obesity	0.00136	0.0292	CbGeAlD
Levonorgestrel—Norelgestromin—STS—obesity	0.00125	0.235	CrCbGaD
Levonorgestrel—ESR1—hindbrain—obesity	0.0012	0.0259	CbGeAlD
Levonorgestrel—PGR—respiratory system—obesity	0.000939	0.0202	CbGeAlD
Levonorgestrel—SHBG—cardiovascular system—obesity	0.000798	0.0172	CbGeAlD
Levonorgestrel—ESR1—respiratory system—obesity	0.000734	0.0158	CbGeAlD
Levonorgestrel—PGR—cardiovascular system—obesity	0.000719	0.0155	CbGeAlD
Levonorgestrel—SHBG—pituitary gland—obesity	0.000707	0.0152	CbGeAlD
Levonorgestrel—SHBG—adipose tissue—obesity	0.000704	0.0152	CbGeAlD
Levonorgestrel—PGR—pituitary gland—obesity	0.000637	0.0137	CbGeAlD
Levonorgestrel—PGR—adipose tissue—obesity	0.000634	0.0137	CbGeAlD
Levonorgestrel—SHBG—adrenal gland—obesity	0.000631	0.0136	CbGeAlD
Levonorgestrel—AR—adrenal cortex—obesity	0.000628	0.0135	CbGeAlD
Levonorgestrel—AR—cardiovascular system—obesity	0.000573	0.0123	CbGeAlD
Levonorgestrel—CYP19A1—adipose tissue—obesity	0.000571	0.0123	CbGeAlD
Levonorgestrel—PGR—adrenal gland—obesity	0.000569	0.0123	CbGeAlD
Levonorgestrel—ESR1—cardiovascular system—obesity	0.000562	0.0121	CbGeAlD
Levonorgestrel—SHBG—endocrine gland—obesity	0.000548	0.0118	CbGeAlD
Levonorgestrel—CYP19A1—adrenal gland—obesity	0.000512	0.011	CbGeAlD
Levonorgestrel—AR—pituitary gland—obesity	0.000507	0.0109	CbGeAlD
Levonorgestrel—AR—adipose tissue—obesity	0.000505	0.0109	CbGeAlD
Levonorgestrel—ESR1—pituitary gland—obesity	0.000498	0.0107	CbGeAlD
Levonorgestrel—ESR1—adipose tissue—obesity	0.000496	0.0107	CbGeAlD
Levonorgestrel—SHBG—liver—obesity	0.000494	0.0106	CbGeAlD
Levonorgestrel—PGR—endocrine gland—obesity	0.000493	0.0106	CbGeAlD
Levonorgestrel—AR—digestive system—obesity	0.000476	0.0102	CbGeAlD
Levonorgestrel—ESR1—digestive system—obesity	0.000467	0.0101	CbGeAlD
Levonorgestrel—AR—adrenal gland—obesity	0.000453	0.00977	CbGeAlD
Levonorgestrel—ESR1—adrenal gland—obesity	0.000445	0.00959	CbGeAlD
Levonorgestrel—CYP19A1—endocrine gland—obesity	0.000444	0.00957	CbGeAlD
Levonorgestrel—CYP19A1—liver—obesity	0.0004	0.00862	CbGeAlD
Levonorgestrel—AR—endocrine gland—obesity	0.000393	0.00847	CbGeAlD
Levonorgestrel—ESR1—endocrine gland—obesity	0.000386	0.00831	CbGeAlD
Levonorgestrel—AR—liver—obesity	0.000354	0.00764	CbGeAlD
Levonorgestrel—ESR1—liver—obesity	0.000348	0.0075	CbGeAlD
Levonorgestrel—CYP3A4—digestive system—obesity	0.00026	0.00561	CbGeAlD
Levonorgestrel—CYP3A4—endocrine gland—obesity	0.000215	0.00464	CbGeAlD
Levonorgestrel—Desogestrel—SHBG—obesity	0.000199	0.0374	CrCbGaD
Levonorgestrel—Nandrolone phenpropionate—AR—obesity	0.000198	0.0372	CrCbGaD
Levonorgestrel—CYP3A4—liver—obesity	0.000194	0.00418	CbGeAlD
Levonorgestrel—Danazol—CCL2—obesity	0.000182	0.0343	CrCbGaD
Levonorgestrel—Quinestrol—ESR1—obesity	0.000179	0.0337	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—NR1I2—obesity	0.000167	0.0314	CrCbGaD
Levonorgestrel—Nandrolone phenpropionate—CYP19A1—obesity	0.000165	0.0312	CrCbGaD
Levonorgestrel—Etonogestrel—SHBG—obesity	0.000161	0.0303	CrCbGaD
Levonorgestrel—Dermatitis—Diethylpropion—obesity	0.000152	0.00109	CcSEcCtD
Levonorgestrel—Dizziness—Cimetidine—obesity	0.000152	0.00109	CcSEcCtD
Levonorgestrel—Haemoglobin—Bupropion—obesity	0.000151	0.00108	CcSEcCtD
Levonorgestrel—Headache—Diethylpropion—obesity	0.000151	0.00108	CcSEcCtD
Levonorgestrel—Rhinitis—Bupropion—obesity	0.000151	0.00108	CcSEcCtD
Levonorgestrel—Haemorrhage—Bupropion—obesity	0.00015	0.00108	CcSEcCtD
Levonorgestrel—Malnutrition—Sibutramine—obesity	0.00015	0.00108	CcSEcCtD
Levonorgestrel—Back pain—Orlistat—obesity	0.00015	0.00108	CcSEcCtD
Levonorgestrel—Nandrolone decanoate—AR—obesity	0.00015	0.0282	CrCbGaD
Levonorgestrel—Hypoaesthesia—Bupropion—obesity	0.00015	0.00107	CcSEcCtD
Levonorgestrel—Libido decreased—Topiramate—obesity	0.000149	0.00107	CcSEcCtD
Levonorgestrel—Pharyngitis—Bupropion—obesity	0.000149	0.00107	CcSEcCtD
Levonorgestrel—Muscle spasms—Orlistat—obesity	0.000149	0.00107	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Bupropion—obesity	0.000149	0.00107	CcSEcCtD
Levonorgestrel—Flatulence—Sibutramine—obesity	0.000148	0.00106	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Bupropion—obesity	0.000148	0.00106	CcSEcCtD
Levonorgestrel—Urethral disorder—Bupropion—obesity	0.000148	0.00106	CcSEcCtD
Levonorgestrel—Increased appetite—Topiramate—obesity	0.000148	0.00106	CcSEcCtD
Levonorgestrel—Ethynodiol—ESR1—obesity	0.000148	0.0278	CrCbGaD
Levonorgestrel—Tension—Sibutramine—obesity	0.000147	0.00106	CcSEcCtD
Levonorgestrel—Nervousness—Sibutramine—obesity	0.000146	0.00105	CcSEcCtD
Levonorgestrel—Vomiting—Cimetidine—obesity	0.000146	0.00105	CcSEcCtD
Levonorgestrel—Back pain—Sibutramine—obesity	0.000145	0.00104	CcSEcCtD
Levonorgestrel—Visual impairment—Bupropion—obesity	0.000145	0.00104	CcSEcCtD
Levonorgestrel—Rash—Cimetidine—obesity	0.000145	0.00104	CcSEcCtD
Levonorgestrel—Dermatitis—Cimetidine—obesity	0.000145	0.00104	CcSEcCtD
Levonorgestrel—Muscle spasms—Sibutramine—obesity	0.000144	0.00104	CcSEcCtD
Levonorgestrel—Headache—Cimetidine—obesity	0.000144	0.00103	CcSEcCtD
Levonorgestrel—Purpura—Topiramate—obesity	0.000144	0.00103	CcSEcCtD
Levonorgestrel—Nausea—Diethylpropion—obesity	0.000143	0.00103	CcSEcCtD
Levonorgestrel—Erythema multiforme—Bupropion—obesity	0.000142	0.00102	CcSEcCtD
Levonorgestrel—Angioedema—Orlistat—obesity	0.000142	0.00102	CcSEcCtD
Levonorgestrel—Eye disorder—Bupropion—obesity	0.000141	0.00101	CcSEcCtD
Levonorgestrel—Cardiac disorder—Bupropion—obesity	0.00014	0.001	CcSEcCtD
Levonorgestrel—Vertigo—Orlistat—obesity	0.00014	0.001	CcSEcCtD
Levonorgestrel—Allylestrenol—ESR1—obesity	0.000139	0.0262	CrCbGaD
Levonorgestrel—Anaemia—Sibutramine—obesity	0.000139	0.000996	CcSEcCtD
Levonorgestrel—Pain in extremity—Topiramate—obesity	0.000139	0.000994	CcSEcCtD
Levonorgestrel—Disturbance in sexual arousal—Topiramate—obesity	0.000137	0.000986	CcSEcCtD
Levonorgestrel—Testosterone Propionate—COMT—obesity	0.000137	0.0259	CrCbGaD
Levonorgestrel—Angioedema—Sibutramine—obesity	0.000137	0.000985	CcSEcCtD
Levonorgestrel—Palpitations—Orlistat—obesity	0.000137	0.000984	CcSEcCtD
Levonorgestrel—Affect lability—Topiramate—obesity	0.000136	0.000978	CcSEcCtD
Levonorgestrel—Migraine—Topiramate—obesity	0.000136	0.000978	CcSEcCtD
Levonorgestrel—Nausea—Cimetidine—obesity	0.000136	0.000978	CcSEcCtD
Levonorgestrel—Immune system disorder—Bupropion—obesity	0.000136	0.000975	CcSEcCtD
Levonorgestrel—Mestranol—ESR1—obesity	0.000136	0.0256	CrCbGaD
Levonorgestrel—Mediastinal disorder—Bupropion—obesity	0.000136	0.000972	CcSEcCtD
Levonorgestrel—Cough—Orlistat—obesity	0.000135	0.000972	CcSEcCtD
Levonorgestrel—Vertigo—Sibutramine—obesity	0.000135	0.000968	CcSEcCtD
Levonorgestrel—Syncope—Sibutramine—obesity	0.000135	0.000966	CcSEcCtD
Levonorgestrel—Arrhythmia—Bupropion—obesity	0.000134	0.000964	CcSEcCtD
Levonorgestrel—Desogestrel—ESR1—obesity	0.000134	0.0253	CrCbGaD
Levonorgestrel—Alopecia—Bupropion—obesity	0.000133	0.000954	CcSEcCtD
Levonorgestrel—Palpitations—Sibutramine—obesity	0.000133	0.000952	CcSEcCtD
Levonorgestrel—Chest pain—Orlistat—obesity	0.000132	0.000948	CcSEcCtD
Levonorgestrel—Myalgia—Orlistat—obesity	0.000132	0.000948	CcSEcCtD
Levonorgestrel—Loss of consciousness—Sibutramine—obesity	0.000132	0.000947	CcSEcCtD
Levonorgestrel—Mental disorder—Bupropion—obesity	0.000132	0.000945	CcSEcCtD
Levonorgestrel—Anxiety—Orlistat—obesity	0.000132	0.000945	CcSEcCtD
Levonorgestrel—Mood swings—Topiramate—obesity	0.000131	0.000941	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000131	0.000941	CcSEcCtD
Levonorgestrel—Cough—Sibutramine—obesity	0.000131	0.00094	CcSEcCtD
Levonorgestrel—Malnutrition—Bupropion—obesity	0.000131	0.000939	CcSEcCtD
Levonorgestrel—Discomfort—Orlistat—obesity	0.000131	0.000936	CcSEcCtD
Levonorgestrel—Hypertension—Sibutramine—obesity	0.00013	0.00093	CcSEcCtD
Levonorgestrel—Flatulence—Bupropion—obesity	0.000129	0.000926	CcSEcCtD
Levonorgestrel—Tension—Bupropion—obesity	0.000129	0.000922	CcSEcCtD
Levonorgestrel—Chest pain—Sibutramine—obesity	0.000128	0.000917	CcSEcCtD
Levonorgestrel—Myalgia—Sibutramine—obesity	0.000128	0.000917	CcSEcCtD
Levonorgestrel—Anxiety—Sibutramine—obesity	0.000127	0.000914	CcSEcCtD
Levonorgestrel—Nervousness—Bupropion—obesity	0.000127	0.000912	CcSEcCtD
Levonorgestrel—Oedema—Orlistat—obesity	0.000127	0.000909	CcSEcCtD
Levonorgestrel—Back pain—Bupropion—obesity	0.000127	0.000909	CcSEcCtD
Levonorgestrel—Discomfort—Sibutramine—obesity	0.000126	0.000906	CcSEcCtD
Levonorgestrel—Muscle spasms—Bupropion—obesity	0.000126	0.000903	CcSEcCtD
Levonorgestrel—Infection—Orlistat—obesity	0.000126	0.000903	CcSEcCtD
Levonorgestrel—Norgestimate—ESR1—obesity	0.000125	0.0236	CrCbGaD
Levonorgestrel—Nandrolone decanoate—CYP19A1—obesity	0.000125	0.0236	CrCbGaD
Levonorgestrel—Breast disorder—Topiramate—obesity	0.000125	0.000898	CcSEcCtD
Levonorgestrel—Nervous system disorder—Orlistat—obesity	0.000124	0.000891	CcSEcCtD
Levonorgestrel—Skin disorder—Orlistat—obesity	0.000123	0.000883	CcSEcCtD
Levonorgestrel—Oedema—Sibutramine—obesity	0.000123	0.000879	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Orlistat—obesity	0.000123	0.000878	CcSEcCtD
Levonorgestrel—Infection—Sibutramine—obesity	0.000122	0.000874	CcSEcCtD
Levonorgestrel—Anaemia—Bupropion—obesity	0.000121	0.000868	CcSEcCtD
Levonorgestrel—Shock—Sibutramine—obesity	0.000121	0.000865	CcSEcCtD
Levonorgestrel—Abdominal distension—Topiramate—obesity	0.000121	0.000865	CcSEcCtD
Levonorgestrel—Asthma—Topiramate—obesity	0.00012	0.000859	CcSEcCtD
Levonorgestrel—Angioedema—Bupropion—obesity	0.00012	0.000858	CcSEcCtD
Levonorgestrel—Skin disorder—Sibutramine—obesity	0.000119	0.000854	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Sibutramine—obesity	0.000119	0.00085	CcSEcCtD
Levonorgestrel—Vertigo—Bupropion—obesity	0.000118	0.000844	CcSEcCtD
Levonorgestrel—Syncope—Bupropion—obesity	0.000117	0.000842	CcSEcCtD
Levonorgestrel—Anorexia—Sibutramine—obesity	0.000117	0.000838	CcSEcCtD
Levonorgestrel—Sweating increased—Topiramate—obesity	0.000117	0.000837	CcSEcCtD
Levonorgestrel—Palpitations—Bupropion—obesity	0.000116	0.00083	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Orlistat—obesity	0.000115	0.000828	CcSEcCtD
Levonorgestrel—Bronchitis—Topiramate—obesity	0.000115	0.000826	CcSEcCtD
Levonorgestrel—Loss of consciousness—Bupropion—obesity	0.000115	0.000826	CcSEcCtD
Levonorgestrel—Insomnia—Orlistat—obesity	0.000115	0.000822	CcSEcCtD
Levonorgestrel—Cough—Bupropion—obesity	0.000114	0.00082	CcSEcCtD
Levonorgestrel—Hypertension—Bupropion—obesity	0.000113	0.000811	CcSEcCtD
Levonorgestrel—Dysuria—Topiramate—obesity	0.000112	0.000803	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Sibutramine—obesity	0.000112	0.000801	CcSEcCtD
Levonorgestrel—Dyspepsia—Orlistat—obesity	0.000112	0.0008	CcSEcCtD
Levonorgestrel—Myalgia—Bupropion—obesity	0.000112	0.0008	CcSEcCtD
Levonorgestrel—Chest pain—Bupropion—obesity	0.000112	0.0008	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Topiramate—obesity	0.000111	0.000798	CcSEcCtD
Levonorgestrel—Anxiety—Bupropion—obesity	0.000111	0.000797	CcSEcCtD
Levonorgestrel—Insomnia—Sibutramine—obesity	0.000111	0.000795	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000111	0.000794	CcSEcCtD
Levonorgestrel—Pollakiuria—Topiramate—obesity	0.000111	0.000793	CcSEcCtD
Levonorgestrel—Discomfort—Bupropion—obesity	0.00011	0.00079	CcSEcCtD
Levonorgestrel—Decreased appetite—Orlistat—obesity	0.00011	0.00079	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Orlistat—obesity	0.000109	0.000784	CcSEcCtD
Levonorgestrel—Dyspnoea—Sibutramine—obesity	0.000109	0.000784	CcSEcCtD
Levonorgestrel—Fatigue—Orlistat—obesity	0.000109	0.000783	CcSEcCtD
Levonorgestrel—Somnolence—Sibutramine—obesity	0.000109	0.000782	CcSEcCtD
Levonorgestrel—Weight increased—Topiramate—obesity	0.000109	0.000782	CcSEcCtD
Levonorgestrel—Etonogestrel—ESR1—obesity	0.000109	0.0204	CrCbGaD
Levonorgestrel—Weight decreased—Topiramate—obesity	0.000108	0.000777	CcSEcCtD
Levonorgestrel—Pain—Orlistat—obesity	0.000108	0.000777	CcSEcCtD
Levonorgestrel—Dyspepsia—Sibutramine—obesity	0.000108	0.000774	CcSEcCtD
Levonorgestrel—Pneumonia—Topiramate—obesity	0.000107	0.00077	CcSEcCtD
Levonorgestrel—Oedema—Bupropion—obesity	0.000107	0.000767	CcSEcCtD
Levonorgestrel—Infestation NOS—Topiramate—obesity	0.000107	0.000766	CcSEcCtD
Levonorgestrel—Infestation—Topiramate—obesity	0.000107	0.000766	CcSEcCtD
Levonorgestrel—Decreased appetite—Sibutramine—obesity	0.000107	0.000764	CcSEcCtD
Levonorgestrel—Depression—Topiramate—obesity	0.000106	0.000764	CcSEcCtD
Levonorgestrel—Infection—Bupropion—obesity	0.000106	0.000762	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Sibutramine—obesity	0.000106	0.000759	CcSEcCtD
Levonorgestrel—Shock—Bupropion—obesity	0.000105	0.000754	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—ESR2—obesity	0.000105	0.0198	CrCbGaD
Levonorgestrel—Pain—Sibutramine—obesity	0.000105	0.000752	CcSEcCtD
Levonorgestrel—Constipation—Sibutramine—obesity	0.000105	0.000752	CcSEcCtD
Levonorgestrel—Nervous system disorder—Bupropion—obesity	0.000105	0.000752	CcSEcCtD
Levonorgestrel—Skin disorder—Bupropion—obesity	0.000104	0.000745	CcSEcCtD
Levonorgestrel—Urinary tract infection—Topiramate—obesity	0.000104	0.000744	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Orlistat—obesity	0.000104	0.000743	CcSEcCtD
Levonorgestrel—Danazol—SHBG—obesity	0.000104	0.0195	CrCbGaD
Levonorgestrel—Hyperhidrosis—Bupropion—obesity	0.000103	0.000741	CcSEcCtD
Levonorgestrel—Testosterone Propionate—AR—obesity	0.000103	0.0193	CrCbGaD
Levonorgestrel—Anorexia—Bupropion—obesity	0.000102	0.000731	CcSEcCtD
Levonorgestrel—Urticaria—Orlistat—obesity	0.000101	0.000722	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Sibutramine—obesity	0.0001	0.000719	CcSEcCtD
Levonorgestrel—Sinusitis—Topiramate—obesity	0.0001	0.000718	CcSEcCtD
Levonorgestrel—Body temperature increased—Orlistat—obesity	0.0001	0.000718	CcSEcCtD
Levonorgestrel—Abdominal pain—Orlistat—obesity	0.0001	0.000718	CcSEcCtD
Levonorgestrel—Urticaria—Sibutramine—obesity	9.74e-05	0.000699	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Bupropion—obesity	9.74e-05	0.000698	CcSEcCtD
Levonorgestrel—Abdominal pain—Sibutramine—obesity	9.7e-05	0.000695	CcSEcCtD
Levonorgestrel—Body temperature increased—Sibutramine—obesity	9.7e-05	0.000695	CcSEcCtD
Levonorgestrel—Insomnia—Bupropion—obesity	9.67e-05	0.000693	CcSEcCtD
Levonorgestrel—Haemoglobin—Topiramate—obesity	9.64e-05	0.000691	CcSEcCtD
Levonorgestrel—Rhinitis—Topiramate—obesity	9.61e-05	0.000689	CcSEcCtD
Levonorgestrel—Haemorrhage—Topiramate—obesity	9.59e-05	0.000687	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—SHBG—obesity	9.58e-05	0.018	CrCbGaD
Levonorgestrel—Hypoaesthesia—Topiramate—obesity	9.54e-05	0.000684	CcSEcCtD
Levonorgestrel—Dyspnoea—Bupropion—obesity	9.53e-05	0.000683	CcSEcCtD
Levonorgestrel—Pharyngitis—Topiramate—obesity	9.52e-05	0.000682	CcSEcCtD
Levonorgestrel—Somnolence—Bupropion—obesity	9.5e-05	0.000682	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Topiramate—obesity	9.47e-05	0.000679	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Topiramate—obesity	9.42e-05	0.000676	CcSEcCtD
Levonorgestrel—Dyspepsia—Bupropion—obesity	9.41e-05	0.000675	CcSEcCtD
Levonorgestrel—Urethral disorder—Topiramate—obesity	9.4e-05	0.000674	CcSEcCtD
Levonorgestrel—Hypersensitivity—Orlistat—obesity	9.34e-05	0.000669	CcSEcCtD
Levonorgestrel—Decreased appetite—Bupropion—obesity	9.29e-05	0.000666	CcSEcCtD
Levonorgestrel—Visual impairment—Topiramate—obesity	9.24e-05	0.000663	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Bupropion—obesity	9.23e-05	0.000662	CcSEcCtD
Levonorgestrel—Fatigue—Bupropion—obesity	9.22e-05	0.000661	CcSEcCtD
Levonorgestrel—Norethindrone—SHBG—obesity	9.21e-05	0.0174	CrCbGaD
Levonorgestrel—Pain—Bupropion—obesity	9.14e-05	0.000656	CcSEcCtD
Levonorgestrel—Constipation—Bupropion—obesity	9.14e-05	0.000656	CcSEcCtD
Levonorgestrel—Asthenia—Orlistat—obesity	9.09e-05	0.000652	CcSEcCtD
Levonorgestrel—Danazol—AR—obesity	9.08e-05	0.0171	CrCbGaD
Levonorgestrel—Erythema multiforme—Topiramate—obesity	9.07e-05	0.00065	CcSEcCtD
Levonorgestrel—Hypersensitivity—Sibutramine—obesity	9.04e-05	0.000648	CcSEcCtD
Levonorgestrel—Pruritus—Orlistat—obesity	8.97e-05	0.000643	CcSEcCtD
Levonorgestrel—Eye disorder—Topiramate—obesity	8.96e-05	0.000642	CcSEcCtD
Levonorgestrel—Cardiac disorder—Topiramate—obesity	8.9e-05	0.000638	CcSEcCtD
Levonorgestrel—Asthenia—Sibutramine—obesity	8.8e-05	0.000631	CcSEcCtD
Levonorgestrel—Methyltestosterone—SHBG—obesity	8.75e-05	0.0165	CrCbGaD
Levonorgestrel—Gastrointestinal pain—Bupropion—obesity	8.74e-05	0.000627	CcSEcCtD
Levonorgestrel—Pruritus—Sibutramine—obesity	8.68e-05	0.000622	CcSEcCtD
Levonorgestrel—Diarrhoea—Orlistat—obesity	8.67e-05	0.000622	CcSEcCtD
Levonorgestrel—Immune system disorder—Topiramate—obesity	8.66e-05	0.000621	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Topiramate—obesity	8.64e-05	0.00062	CcSEcCtD
Levonorgestrel—Urticaria—Bupropion—obesity	8.49e-05	0.000609	CcSEcCtD
Levonorgestrel—Alopecia—Topiramate—obesity	8.47e-05	0.000607	CcSEcCtD
Levonorgestrel—Abdominal pain—Bupropion—obesity	8.45e-05	0.000606	CcSEcCtD
Levonorgestrel—Body temperature increased—Bupropion—obesity	8.45e-05	0.000606	CcSEcCtD
Levonorgestrel—Mental disorder—Topiramate—obesity	8.4e-05	0.000602	CcSEcCtD
Levonorgestrel—Diarrhoea—Sibutramine—obesity	8.39e-05	0.000602	CcSEcCtD
Levonorgestrel—Dizziness—Orlistat—obesity	8.38e-05	0.000601	CcSEcCtD
Levonorgestrel—Malnutrition—Topiramate—obesity	8.35e-05	0.000598	CcSEcCtD
Levonorgestrel—Erythema—Topiramate—obesity	8.35e-05	0.000598	CcSEcCtD
Levonorgestrel—Flatulence—Topiramate—obesity	8.22e-05	0.00059	CcSEcCtD
Levonorgestrel—Tension—Topiramate—obesity	8.19e-05	0.000587	CcSEcCtD
Levonorgestrel—Dizziness—Sibutramine—obesity	8.11e-05	0.000582	CcSEcCtD
Levonorgestrel—Nervousness—Topiramate—obesity	8.11e-05	0.000581	CcSEcCtD
Levonorgestrel—Back pain—Topiramate—obesity	8.07e-05	0.000579	CcSEcCtD
Levonorgestrel—Vomiting—Orlistat—obesity	8.06e-05	0.000578	CcSEcCtD
Levonorgestrel—Muscle spasms—Topiramate—obesity	8.02e-05	0.000575	CcSEcCtD
Levonorgestrel—Rash—Orlistat—obesity	7.99e-05	0.000573	CcSEcCtD
Levonorgestrel—Dermatitis—Orlistat—obesity	7.98e-05	0.000572	CcSEcCtD
Levonorgestrel—Headache—Orlistat—obesity	7.94e-05	0.000569	CcSEcCtD
Levonorgestrel—Hypersensitivity—Bupropion—obesity	7.88e-05	0.000565	CcSEcCtD
Levonorgestrel—Vomiting—Sibutramine—obesity	7.8e-05	0.000559	CcSEcCtD
Levonorgestrel—Rash—Sibutramine—obesity	7.73e-05	0.000554	CcSEcCtD
Levonorgestrel—Dermatitis—Sibutramine—obesity	7.73e-05	0.000554	CcSEcCtD
Levonorgestrel—Anaemia—Topiramate—obesity	7.71e-05	0.000553	CcSEcCtD
Levonorgestrel—Headache—Sibutramine—obesity	7.68e-05	0.000551	CcSEcCtD
Levonorgestrel—Asthenia—Bupropion—obesity	7.67e-05	0.00055	CcSEcCtD
Levonorgestrel—Methyltestosterone—AR—obesity	7.67e-05	0.0144	CrCbGaD
Levonorgestrel—Danazol—CYP19A1—obesity	7.6e-05	0.0143	CrCbGaD
Levonorgestrel—Pruritus—Bupropion—obesity	7.56e-05	0.000542	CcSEcCtD
Levonorgestrel—Nausea—Orlistat—obesity	7.53e-05	0.00054	CcSEcCtD
Levonorgestrel—Vertigo—Topiramate—obesity	7.5e-05	0.000538	CcSEcCtD
Levonorgestrel—Syncope—Topiramate—obesity	7.48e-05	0.000537	CcSEcCtD
Levonorgestrel—Palpitations—Topiramate—obesity	7.38e-05	0.000529	CcSEcCtD
Levonorgestrel—Loss of consciousness—Topiramate—obesity	7.34e-05	0.000526	CcSEcCtD
Levonorgestrel—Diarrhoea—Bupropion—obesity	7.32e-05	0.000525	CcSEcCtD
Levonorgestrel—Nausea—Sibutramine—obesity	7.28e-05	0.000522	CcSEcCtD
Levonorgestrel—Cough—Topiramate—obesity	7.28e-05	0.000522	CcSEcCtD
Levonorgestrel—Hypertension—Topiramate—obesity	7.21e-05	0.000517	CcSEcCtD
Levonorgestrel—Myalgia—Topiramate—obesity	7.11e-05	0.000509	CcSEcCtD
Levonorgestrel—Chest pain—Topiramate—obesity	7.11e-05	0.000509	CcSEcCtD
Levonorgestrel—Anxiety—Topiramate—obesity	7.08e-05	0.000508	CcSEcCtD
Levonorgestrel—Dizziness—Bupropion—obesity	7.07e-05	0.000507	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	7.06e-05	0.000506	CcSEcCtD
Levonorgestrel—Discomfort—Topiramate—obesity	7.02e-05	0.000503	CcSEcCtD
Levonorgestrel—Danazol—ESR1—obesity	6.99e-05	0.0132	CrCbGaD
Levonorgestrel—Oedema—Topiramate—obesity	6.81e-05	0.000488	CcSEcCtD
Levonorgestrel—Vomiting—Bupropion—obesity	6.8e-05	0.000487	CcSEcCtD
Levonorgestrel—Infection—Topiramate—obesity	6.77e-05	0.000485	CcSEcCtD
Levonorgestrel—Rash—Bupropion—obesity	6.74e-05	0.000483	CcSEcCtD
Levonorgestrel—Dermatitis—Bupropion—obesity	6.74e-05	0.000483	CcSEcCtD
Levonorgestrel—Shock—Topiramate—obesity	6.7e-05	0.000481	CcSEcCtD
Levonorgestrel—Headache—Bupropion—obesity	6.7e-05	0.00048	CcSEcCtD
Levonorgestrel—Nervous system disorder—Topiramate—obesity	6.68e-05	0.000479	CcSEcCtD
Levonorgestrel—Skin disorder—Topiramate—obesity	6.62e-05	0.000474	CcSEcCtD
Levonorgestrel—Hydrocortisone—SHBG—obesity	6.59e-05	0.0124	CrCbGaD
Levonorgestrel—Hyperhidrosis—Topiramate—obesity	6.59e-05	0.000472	CcSEcCtD
Levonorgestrel—Anorexia—Topiramate—obesity	6.49e-05	0.000466	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—ESR1—obesity	6.47e-05	0.0122	CrCbGaD
Levonorgestrel—Methyltestosterone—CYP19A1—obesity	6.42e-05	0.0121	CrCbGaD
Levonorgestrel—Nausea—Bupropion—obesity	6.35e-05	0.000455	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Topiramate—obesity	6.21e-05	0.000445	CcSEcCtD
Levonorgestrel—Insomnia—Topiramate—obesity	6.16e-05	0.000442	CcSEcCtD
Levonorgestrel—Dyspnoea—Topiramate—obesity	6.07e-05	0.000435	CcSEcCtD
Levonorgestrel—Somnolence—Topiramate—obesity	6.06e-05	0.000434	CcSEcCtD
Levonorgestrel—Dyspepsia—Topiramate—obesity	6e-05	0.00043	CcSEcCtD
Levonorgestrel—Decreased appetite—Topiramate—obesity	5.92e-05	0.000425	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Topiramate—obesity	5.88e-05	0.000422	CcSEcCtD
Levonorgestrel—Fatigue—Topiramate—obesity	5.87e-05	0.000421	CcSEcCtD
Levonorgestrel—Constipation—Topiramate—obesity	5.83e-05	0.000418	CcSEcCtD
Levonorgestrel—Pain—Topiramate—obesity	5.83e-05	0.000418	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Topiramate—obesity	5.57e-05	0.000399	CcSEcCtD
Levonorgestrel—Urticaria—Topiramate—obesity	5.41e-05	0.000388	CcSEcCtD
Levonorgestrel—Abdominal pain—Topiramate—obesity	5.38e-05	0.000386	CcSEcCtD
Levonorgestrel—Body temperature increased—Topiramate—obesity	5.38e-05	0.000386	CcSEcCtD
Levonorgestrel—Progesterone—SHBG—obesity	5.37e-05	0.0101	CrCbGaD
Levonorgestrel—Progesterone—SLC22A1—obesity	5.3e-05	0.00998	CrCbGaD
Levonorgestrel—Testosterone—SHBG—obesity	5.07e-05	0.00956	CrCbGaD
Levonorgestrel—Hypersensitivity—Topiramate—obesity	5.02e-05	0.00036	CcSEcCtD
Levonorgestrel—Testosterone—SLC22A1—obesity	5.01e-05	0.00943	CrCbGaD
Levonorgestrel—Asthenia—Topiramate—obesity	4.89e-05	0.00035	CcSEcCtD
Levonorgestrel—Pruritus—Topiramate—obesity	4.82e-05	0.000346	CcSEcCtD
Levonorgestrel—Progesterone—AR—obesity	4.71e-05	0.00887	CrCbGaD
Levonorgestrel—Diarrhoea—Topiramate—obesity	4.66e-05	0.000334	CcSEcCtD
Levonorgestrel—Dizziness—Topiramate—obesity	4.5e-05	0.000323	CcSEcCtD
Levonorgestrel—Testosterone—AR—obesity	4.45e-05	0.00838	CrCbGaD
Levonorgestrel—Vomiting—Topiramate—obesity	4.33e-05	0.000311	CcSEcCtD
Levonorgestrel—Rash—Topiramate—obesity	4.29e-05	0.000308	CcSEcCtD
Levonorgestrel—Dermatitis—Topiramate—obesity	4.29e-05	0.000308	CcSEcCtD
Levonorgestrel—Headache—Topiramate—obesity	4.27e-05	0.000306	CcSEcCtD
Levonorgestrel—Nausea—Topiramate—obesity	4.05e-05	0.00029	CcSEcCtD
Levonorgestrel—Hydrocortisone—NR3C1—obesity	3.92e-05	0.00738	CrCbGaD
Levonorgestrel—Testosterone—CYP19A1—obesity	3.72e-05	0.00702	CrCbGaD
Levonorgestrel—Progesterone—ESR1—obesity	3.63e-05	0.00683	CrCbGaD
Levonorgestrel—Progesterone—NR3C1—obesity	3.19e-05	0.00601	CrCbGaD
Levonorgestrel—Norethindrone—ALB—obesity	2.77e-05	0.00522	CrCbGaD
Levonorgestrel—Methyltestosterone—ALB—obesity	2.63e-05	0.00496	CrCbGaD
Levonorgestrel—Testosterone—ALB—obesity	1.53e-05	0.00287	CrCbGaD
Levonorgestrel—CYP3A4—Metabolism—PNPLA3—obesity	7.96e-06	9.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UCP1—obesity	7.96e-06	9.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COX7C—obesity	7.96e-06	9.36e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKR1C3—obesity	7.91e-06	9.3e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR2A—obesity	7.9e-06	9.29e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—C3—obesity	7.89e-06	9.28e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NPS—obesity	7.71e-06	9.07e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—COMT—obesity	7.65e-06	9e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2C—obesity	7.56e-06	8.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DRD1—obesity	7.56e-06	8.89e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SUCLA2—obesity	7.55e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CPS1—obesity	7.55e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DGAT2—obesity	7.55e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CS—obesity	7.55e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GNB3—obesity	7.55e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARGC1A—obesity	7.55e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—obesity	7.51e-06	8.83e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS2—obesity	7.5e-06	8.83e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—obesity	7.5e-06	8.82e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AGT—obesity	7.5e-06	8.82e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR3C1—obesity	7.46e-06	8.77e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK2—obesity	7.35e-06	8.65e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GNAS—obesity	7.35e-06	8.64e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LEP—obesity	7.34e-06	8.64e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOE—obesity	7.34e-06	8.64e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB1—obesity	7.32e-06	8.61e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PRKCD—obesity	7.29e-06	8.57e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CAV1—obesity	7.28e-06	8.56e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOA1—obesity	7.26e-06	8.54e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LIPE—obesity	7.2e-06	8.47e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MUT—obesity	7.2e-06	8.47e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOB—obesity	7.19e-06	8.46e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PARP1—obesity	7.16e-06	8.43e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GHRL—obesity	7.16e-06	8.43e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DRD4—obesity	7.11e-06	8.36e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ESR1—obesity	7.01e-06	8.25e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARA—obesity	6.99e-06	8.22e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2—obesity	6.93e-06	8.15e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCB—obesity	6.93e-06	8.15e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DGAT1—obesity	6.9e-06	8.12e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYB5A—obesity	6.9e-06	8.12e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LPL—obesity	6.87e-06	8.08e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BAD—obesity	6.84e-06	8.05e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—obesity	6.84e-06	8.04e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CNR1—obesity	6.79e-06	7.98e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—obesity	6.75e-06	7.94e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GPX1—obesity	6.7e-06	7.88e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TCF7L2—obesity	6.67e-06	7.84e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACLY—obesity	6.64e-06	7.82e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CG—obesity	6.63e-06	7.8e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DRD2—obesity	6.62e-06	7.79e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GCG—obesity	6.55e-06	7.71e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTPN1—obesity	6.55e-06	7.71e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS1—obesity	6.55e-06	7.71e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CD36—obesity	6.53e-06	7.68e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALOX12—obesity	6.42e-06	7.55e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENPP1—obesity	6.42e-06	7.55e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—POMC—obesity	6.31e-06	7.42e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—INS—obesity	6.27e-06	7.38e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRL—obesity	6.25e-06	7.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMGCS1—obesity	6.21e-06	7.31e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—obesity	6.18e-06	7.28e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—obesity	6.17e-06	7.26e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STK11—obesity	6.16e-06	7.25e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLG—obesity	6.09e-06	7.17e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1—obesity	6.07e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARA—obesity	6.07e-06	7.14e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT2—obesity	6.06e-06	7.13e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLIN1—obesity	6.03e-06	7.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SAT1—obesity	6.03e-06	7.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PFKFB3—obesity	6.03e-06	7.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ANGPTL4—obesity	6.03e-06	7.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACADM—obesity	6.03e-06	7.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PNPLA2—obesity	6.03e-06	7.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FOXO3—obesity	5.95e-06	6.99e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB2—obesity	5.93e-06	6.98e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AGT—obesity	5.88e-06	6.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACACB—obesity	5.87e-06	6.9e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—OXCT1—obesity	5.87e-06	6.9e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYTB—obesity	5.87e-06	6.9e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SOCS1—obesity	5.84e-06	6.87e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CD—obesity	5.83e-06	6.85e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—obesity	5.77e-06	6.79e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SOCS3—obesity	5.77e-06	6.79e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—obesity	5.76e-06	6.78e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOE—obesity	5.76e-06	6.77e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SRD5A1—obesity	5.72e-06	6.73e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PNLIP—obesity	5.72e-06	6.73e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAV1—obesity	5.71e-06	6.71e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA1—obesity	5.69e-06	6.7e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNB3—obesity	5.65e-06	6.64e-05	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—obesity	5.61e-06	6.6e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TYK2—obesity	5.61e-06	6.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SDC3—obesity	5.58e-06	6.57e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RHOA—obesity	5.56e-06	6.54e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF2—obesity	5.55e-06	6.53e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—obesity	5.5e-06	6.47e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3R1—obesity	5.5e-06	6.47e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNAS—obesity	5.5e-06	6.47e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HK2—obesity	5.46e-06	6.42e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP26B1—obesity	5.46e-06	6.42e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—STS—obesity	5.46e-06	6.42e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.45e-06	6.41e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOB—obesity	5.39e-06	6.33e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARD—obesity	5.34e-06	6.28e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL5—obesity	5.26e-06	6.19e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC27A1—obesity	5.23e-06	6.15e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—obesity	5.2e-06	6.12e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CG—obesity	5.2e-06	6.11e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LPL—obesity	5.14e-06	6.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—FABP4—obesity	5.13e-06	6.03e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GLUL—obesity	5.13e-06	6.03e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FOXO1—obesity	5.11e-06	6.01e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RPS6KB1—obesity	5.1e-06	5.99e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CB—obesity	5.08e-06	5.97e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MTOR—obesity	5.08e-06	5.97e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—obesity	5.02e-06	5.9e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—POMC—obesity	4.95e-06	5.82e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—INS—obesity	4.92e-06	5.79e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UCP2—obesity	4.86e-06	5.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UCP3—obesity	4.86e-06	5.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD11B1—obesity	4.86e-06	5.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ECHS1—obesity	4.86e-06	5.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADH1B—obesity	4.78e-06	5.63e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCD—obesity	4.74e-06	5.57e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARGC1B—obesity	4.71e-06	5.54e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACSL1—obesity	4.71e-06	5.54e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPAM—obesity	4.71e-06	5.54e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2A—obesity	4.64e-06	5.45e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—C3—obesity	4.63e-06	5.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HADH—obesity	4.57e-06	5.38e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—FADS1—obesity	4.57e-06	5.38e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PCK1—obesity	4.57e-06	5.38e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CD—obesity	4.57e-06	5.37e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—obesity	4.51e-06	5.3e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACP5—obesity	4.45e-06	5.23e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—obesity	4.41e-06	5.19e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS2—obesity	4.4e-06	5.18e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGT—obesity	4.4e-06	5.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—G6PD—obesity	4.33e-06	5.1e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3R1—obesity	4.31e-06	5.07e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—obesity	4.31e-06	5.07e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LEP—obesity	4.31e-06	5.07e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOE—obesity	4.31e-06	5.07e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK8—obesity	4.29e-06	5.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HK1—obesity	4.28e-06	5.04e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SREBF2—obesity	4.28e-06	5.04e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—obesity	4.27e-06	5.03e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CAV1—obesity	4.27e-06	5.02e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA1—obesity	4.26e-06	5.01e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPA—obesity	4.14e-06	4.86e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2—obesity	4.06e-06	4.78e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCB—obesity	4.06e-06	4.78e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPIN1—obesity	4.05e-06	4.76e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BAD—obesity	4.02e-06	4.72e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CB—obesity	3.98e-06	4.68e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA5—obesity	3.96e-06	4.66e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—obesity	3.95e-06	4.64e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—obesity	3.92e-06	4.62e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CG—obesity	3.89e-06	4.58e-05	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—obesity	3.89e-06	4.58e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS1—obesity	3.85e-06	4.52e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC22A1—obesity	3.78e-06	4.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CLOCK—obesity	3.78e-06	4.45e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—POMC—obesity	3.7e-06	4.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SULT2A1—obesity	3.69e-06	4.34e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GLP1R—obesity	3.69e-06	4.34e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INS—obesity	3.68e-06	4.33e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—obesity	3.65e-06	4.29e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—obesity	3.64e-06	4.28e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DPYD—obesity	3.63e-06	4.27e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—obesity	3.62e-06	4.26e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1—obesity	3.56e-06	4.19e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT2—obesity	3.56e-06	4.19e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PRKAR2B—obesity	3.49e-06	4.11e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DCN—obesity	3.47e-06	4.08e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CD—obesity	3.42e-06	4.02e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—obesity	3.38e-06	3.98e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CPT1A—obesity	3.37e-06	3.97e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NAMPT—obesity	3.31e-06	3.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—obesity	3.29e-06	3.87e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TYK2—obesity	3.29e-06	3.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCK—obesity	3.29e-06	3.86e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LIPC—obesity	3.29e-06	3.86e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOC3—obesity	3.26e-06	3.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RHOA—obesity	3.26e-06	3.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3R1—obesity	3.23e-06	3.8e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—obesity	3.23e-06	3.8e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CETP—obesity	3.17e-06	3.73e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SDC1—obesity	3.13e-06	3.69e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—obesity	3.1e-06	3.64e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKR1C3—obesity	3.08e-06	3.63e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SCARB1—obesity	3.04e-06	3.57e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CB—obesity	2.98e-06	3.51e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MTOR—obesity	2.98e-06	3.51e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—obesity	2.96e-06	3.49e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SREBF1—obesity	2.95e-06	3.47e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GOT2—obesity	2.87e-06	3.37e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—FASN—obesity	2.8e-06	3.3e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BCHE—obesity	2.79e-06	3.29e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—obesity	2.74e-06	3.22e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2E1—obesity	2.69e-06	3.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NQO1—obesity	2.66e-06	3.13e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—obesity	2.59e-06	3.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCG—obesity	2.55e-06	3.01e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC2A4—obesity	2.55e-06	3.01e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—obesity	2.53e-06	2.98e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYCS—obesity	2.52e-06	2.97e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK8—obesity	2.52e-06	2.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GGT1—obesity	2.47e-06	2.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GOT1—obesity	2.47e-06	2.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NCOA1—obesity	2.44e-06	2.87e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—obesity	2.43e-06	2.86e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—STK11—obesity	2.4e-06	2.83e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP19A1—obesity	2.4e-06	2.83e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—obesity	2.3e-06	2.71e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—obesity	2.28e-06	2.69e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COMT—obesity	2.23e-06	2.63e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNB3—obesity	2.2e-06	2.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARGC1A—obesity	2.2e-06	2.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—obesity	2.19e-06	2.58e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNAS—obesity	2.14e-06	2.52e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—obesity	2.14e-06	2.52e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—obesity	2.14e-06	2.51e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOB—obesity	2.1e-06	2.47e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPL—obesity	2e-06	2.36e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—obesity	1.98e-06	2.33e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX1—obesity	1.96e-06	2.3e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CD36—obesity	1.9e-06	2.24e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—obesity	1.82e-06	2.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—obesity	1.8e-06	2.12e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARA—obesity	1.77e-06	2.08e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AGT—obesity	1.71e-06	2.02e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOE—obesity	1.68e-06	1.98e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAV1—obesity	1.66e-06	1.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA1—obesity	1.66e-06	1.95e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—obesity	1.61e-06	1.89e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CG—obesity	1.52e-06	1.78e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—obesity	1.48e-06	1.75e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—obesity	1.46e-06	1.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—POMC—obesity	1.44e-06	1.7e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—INS—obesity	1.44e-06	1.69e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CD—obesity	1.33e-06	1.57e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—obesity	1.32e-06	1.55e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—obesity	1.26e-06	1.48e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3R1—obesity	1.26e-06	1.48e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CB—obesity	1.16e-06	1.37e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—obesity	1.15e-06	1.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—obesity	7.08e-07	8.33e-06	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—obesity	5.79e-07	6.81e-06	CbGpPWpGaD
